Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 63 of 663 for:    SMS

Impact of Mobile Phone Texting Service to Support Weight Loss (SMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02985307
Recruitment Status : Enrolling by invitation
First Posted : December 7, 2016
Last Update Posted : March 14, 2019
Sponsor:
Collaborator:
Queen Margaret University
Information provided by (Responsible Party):
NHS Lothian

Brief Summary:
This study evaluates the efficacy of a mobile telehealth short message service as a facilitator for weight management. Half of the participants will receive a standard care weight management group intervention, while the other half will receive daily text messages via their mobile phone to help facilitate weight loss. It is hypothesized that the intervention group receiving text messages will be as successful as the control group at achieving weight loss over a 3-month period.

Condition or disease Intervention/treatment Phase
Obesity Behavioral: Short Message Text Service Behavioral: Standard Weight Management Group Not Applicable

Detailed Description:

Obesity, a chronic progressive disease, has become a major public health concern due to its increasing prevalence and association with many adverse health conditions including type 2 diabetes, many cancers and heart disease. The number of individuals requiring weight management intervention is increasing necessitating the need to explore other initiatives.

Developments in health technology are growing in popularity and there is increasing evidence that this type of intervention for obesity can significantly improve clinical outcomes. Mobile phones are a popular means of communication that provide a convenient, inexpensive means to deliver a health technology intervention.Short message service (SMS) by mobile phone has the potential to serve as an intervention medium to promote weight loss that is accessible and easy to use.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Efficacy of Mobile Telehealth Short Message Service (SMS) as a Facilitator for Weight Management: A Randomised Controlled Trial
Actual Study Start Date : April 28, 2017
Estimated Primary Completion Date : October 31, 2019
Estimated Study Completion Date : December 1, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Short Message Text Service
Participants receive short messages daily via their mobile phone
Behavioral: Short Message Text Service
A service designed by professionals inside the National Health Service (NHS) to provide support and advice for participants to manage weight loss. It combines the expertise of the healthcare team and the convenience of the participant's own mobile phone to give prompts and advice to act on. It makes use of the familiar and convenient mobile phone text service 'SMS' to communicate directly with participants.

Active Comparator: Standard Weight Management Group
Participants attend standard group weight management sessions
Behavioral: Standard Weight Management Group
A standard Lothian NHS group programme facilitated by a Dietitian




Primary Outcome Measures :
  1. Weight Loss [ Time Frame: 3 months ]
    weight recorded in Kg on a Seca 635 medical digital load cell balance


Secondary Outcome Measures :
  1. Behavioural changes necessary for weight loss [ Time Frame: 3 months ]
    Self reported dietary and physical activity changes using 7-day food and exercise diaries

  2. Body fat changes [ Time Frame: 3 months ]
    Measured using a medically approved and validated scale: Tanita SC-240MA body composition analyser

  3. Body Mass index [ Time Frame: 3 months ]
    calculated using the formula weight in kg divided by height squared in metres

  4. Height [ Time Frame: 3months ]
    Height measured using Seca portable stadiometer with a sliding head plate



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Body mass index > 35kg/m requiring to lose weight for an operation or having a co-morbidity including diabetes, osteoarthritis, high cholesterol, asthma, heart disease, high blood pressure or sleep apnoea or with a body mass >40kg/m with no co-morbidities.
  • Own a mobile phone
  • Have the ability to use short message service
  • Have access to weighing scales
  • Mentally capable of informed consent
  • Have the ability to read and speak English

Exclusion Criteria:

  • Uncontrolled Hypothyroidism
  • Poorly controlled psychiatric illness
  • Current alcohol or drug abuse
  • Learning disability
  • Do not own a mobile phone
  • Do not have access to weighing scales
  • Does not have the ability to read or speak English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02985307


Locations
Layout table for location information
United Kingdom
Elizabeth McAnally
Edinburgh, West Lothian, United Kingdom, EH49 6SJ
NHS Lothian
Edinburgh, West Lothian, United Kingdom, EH54 6PP
Sponsors and Collaborators
NHS Lothian
Queen Margaret University
Investigators
Layout table for investigator information
Study Director: Douglas McBean, PhD Queen Margaret University

Additional Information:
Publications of Results:
Layout table for additonal information
Responsible Party: NHS Lothian
ClinicalTrials.gov Identifier: NCT02985307     History of Changes
Other Study ID Numbers: 16/SS/0200
First Posted: December 7, 2016    Key Record Dates
Last Update Posted: March 14, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: De-identified participant data for all primary and secondary outcome measures will be made available within 6months of study completion

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No